Similar articles

• [Autonomy of hormone secretion in insulinoma].

  Beischer W, Kerner W, Raptis S, Herfarth C, Pfeiffer EF. Beischer W, et al. Verh Dtsch Ges Inn Med. 1977 Apr 17-21;83:1410-3. Verh Dtsch Ges Inn Med. 1977. PMID: 206049 German. No abstract available.
• Lack of suppression of insulin secretion by exercise in patients with insulinoma.

  Järhult J, Ericsson M, Holst J, Ingemansson S. Järhult J, et al. Clin Endocrinol (Oxf). 1981 Oct;15(4):391-4. doi: 10.1111/j.1365-2265.1981.tb00679.x. Clin Endocrinol (Oxf). 1981. PMID: 6274547
• C-peptide suppression test for insulinoma.

  Service FJ, Horwitz DL, Rubenstein AH, Kuzuya H, Mako ME, Reynolds C, Molnar GD. Service FJ, et al. J Lab Clin Med. 1977 Jul;90(1):180-6. J Lab Clin Med. 1977. PMID: 194989
• Clinical significance of circulating proinsulin and C-peptide.

  Rubenstein AH, Steiner DF, Horwitz DL, Mako ME, Block MB, Starr JI, Kuzuya H, Melani F. Rubenstein AH, et al. Recent Prog Horm Res. 1976;33:435-75. doi: 10.1016/b978-0-12-571133-3.50017-9. Recent Prog Horm Res. 1976. PMID: 198859 Review. No abstract available.
• Hypoglycemia: tolbutamide and leucine tests in insulinoma.

  Frawley TF, Pensuwan S. Frawley TF, et al. Med Clin North Am. 1968 Mar;52(2):283-94. Med Clin North Am. 1968. PMID: 4297807 Review. No abstract available.